Watanakunakorn P W, Watanakunakorn C, Hazy J
Northeastern Ohio Universities College of Medicine, Rootstown, USA.
Infect Control Hosp Epidemiol. 1996 Apr;17(4):232-5. doi: 10.1086/647286.
To assess risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients, and to test the hypothesis that sucralfate ingestion is associated with nondetection of C difficile cytotoxin in stool specimens.
A retrospective case-control study of hospitalized adult patients who had stool specimens assayed for C difficile cytotoxin. For each patient who had positive C difficile cytotoxin, a patient who had negative C difficile cytotoxin was used as a control. The study period was January to December 1993.
A community teaching hospital affiliated with a medical school in northeastern Ohio.
There were 91 case patients and 91 control patients. Cephalosporin exposure was identified as a risk factor in patients with C difficile diarrhea. The number of patients who had sucralfate ingestion was comparable in both groups of patients.
Administration of cephalosporins was identified as a risk factor in patients with C difficile diarrhea. We were not able to confirm a recent report of the association between ingestion of sucralfate and nondetection of C difficile cytotoxin in stool specimens. Our findings suggest that sucralfate ingestion is not associated with nondetection of C difficile cytotoxin in stool specimens. Assay of C difficile cytotoxin in stool specimens remains a valid method of diagnosing C difficile diarrhea, even in patients who ingest sucralfate.
评估住院成年患者艰难梭菌腹泻的相关危险因素,并检验以下假设,即服用硫糖铝与粪便标本中艰难梭菌细胞毒素检测不到有关。
对住院成年患者进行回顾性病例对照研究,这些患者的粪便标本检测了艰难梭菌细胞毒素。对于每例艰难梭菌细胞毒素检测呈阳性的患者,选取一名艰难梭菌细胞毒素检测呈阴性的患者作为对照。研究时间段为1993年1月至12月。
俄亥俄州东北部一所医学院附属的社区教学医院。
有91例病例患者和91例对照患者。头孢菌素暴露被确定为艰难梭菌腹泻患者的一个危险因素。两组患者中服用硫糖铝的人数相当。
头孢菌素的使用被确定为艰难梭菌腹泻患者的一个危险因素。我们未能证实最近一份关于服用硫糖铝与粪便标本中艰难梭菌细胞毒素检测不到之间关联的报告。我们的研究结果表明,服用硫糖铝与粪便标本中艰难梭菌细胞毒素检测不到无关。即使在服用硫糖铝的患者中,粪便标本中艰难梭菌细胞毒素的检测仍然是诊断艰难梭菌腹泻的有效方法。